Medical Dermatology
Conference Coverage
Systematic approach to pain helps avoid opioid issues for dermatologists
For most skin diseases, dermatologists should take the lead for pain management, but there are exceptions.
Feature
Boosting the presence of darker skin in rheumatology education
Doctors are beginning to address educational gaps in rheumatologists’ exposure to rheumatic and musculoskeletal diseases in people with darker...
Commentary
VEXAS syndrome: Implications for dermatologists
These patients had an autoinflammatory syndrome characterized by fever, chondritis (similar to relapsing polychondritis), vasculitis, and...
From the Journals
Study aims to enhance understanding of ‘tremendously understudied’ prurigo nodularis
“If you encounter a patient with prurigo nodularis, it’s important to perform a screening for chronic kidney disease, diabetes, and liver disease...
Make the Diagnosis
A woman with a history of diabetes, and plaques on both shins
A White female with a history of diabetes mellitus presents with asymptomatic plaques on both shins.
Conference Coverage
Blacks and Hispanics have higher inpatient use for mycosis fungoides
Findings reinforce need to maintain “higher index of suspicion” in these patients.
Conference Coverage
Despite new ichthyosis treatment recommendations, ‘many questions still exist’
“iPLEDGE does impose significant and financial barriers for our patients. More advocacy is needed to adapt that program for our patients.”
Feature
VEXAS: A novel rheumatologic, hematologic syndrome that’s making waves
From the Journals
COVID-19’s impact on lupus inpatients examined in study
Younger inpatients with COVID-19 and SLE showed higher mortality than did COVID-19 inpatients of similar age from the general population in a...
From the Journals
New analysis eyes the surgical landscape for hidradenitis suppurativa
“The influence of patient factors such as comorbidities and disease severity on surgical outcomes is unclear and is a potential area of future...
Conference Coverage
Checkpoint inhibitor–induced rheumatic complications often arise late
Rheumatologic adverse events associated with immune checkpoint inhibitors can happen later in the course of treatment but also can continue after...